- Investing Ideas
- /
- U.S. High Insider Buying
U.S. High Insider Buying
UPDATED Apr 24, 2024
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
555 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALIT | US$9.16 | 1.3% | 1.1% | US$5.3b | US$12.67 | PS1.5x | E119.6% | n/a | Commercial Services | ||
JXN | US$70.60 | 11.1% | 103.6% | US$5.3b | US$65.50 | PE6x | E-5.9% | 4.0% | Diversified Financials | ||
AXS | US$62.58 | 3.1% | 9.4% | US$5.3b | US$75.00 | PE15.3x | E27.8% | 2.8% | Insurance | ||
COOP | US$81.72 | 7.9% | 76.3% | US$5.1b | US$88.63 | PE8.2x | E4.6% | n/a | Diversified Financials | ||
MDU | US$24.69 | 4.8% | -13.8% | US$5.0b | US$25.17 | PE10.5x | E-17.2% | 2.8% | Capital Goods | ||
MMS | US$80.82 | 1.3% | -0.5% | US$4.9b | US$102.50 | PE26.5x | E26.6% | 1.5% | Commercial Services | ||
FNB | US$13.67 | 6.8% | 22.1% | US$4.9b | US$15.67 | PB0.8x | E12.6% | 3.5% | Banks | ||
LNC | US$28.65 | 6.7% | 40.0% | US$4.9b | US$30.00 | PB0.8x | E52.6% | 6.3% | Insurance | ||
ACT | US$30.00 | 2.5% | 27.0% | US$4.7b | US$33.17 | PE7.1x | E-1.7% | 4.5% | Diversified Financials | ||
OGN | US$18.71 | 4.7% | -21.1% | US$4.7b | US$21.50 | PE4.7x | E3.8% | 6.0% | Pharmaceuticals & Biotech | ||
GTES | US$17.77 | 2.9% | 38.3% | US$4.7b | US$19.60 | PE20.1x | E23.8% | n/a | Capital Goods | ||
WU | US$13.59 | 6.2% | 27.6% | US$4.6b | US$13.38 | PE7.4x | E-0.5% | 6.9% | Diversified Financials | ||
BIPC | US$31.78 | 7.1% | -24.6% | US$4.5b | US$40.00 | PE40.9x | S19.1% | 5.1% | Utilities | ||
KNF | US$77.06 | -1.3% | n/a | US$4.4b | US$83.40 | PE23.9x | E10.0% | n/a | Materials | ||
FFIN | US$30.48 | 6.4% | 7.8% | US$4.3b | US$31.40 | PB2.9x | E5.9% | 2.4% | Banks | ||
ALTM | US$3.87 | 2.9% | -56.5% | US$4.2b | US$8.22 | PE12.6x | E32.2% | n/a | Materials | ||
SATS | US$15.88 | 13.3% | -6.0% | US$4.2b | US$21.63 | PB0.2x | E17.8% | n/a | Media | ||
PRGO | US$31.23 | 4.0% | -13.3% | US$4.1b | US$39.72 | PB0.9x | E46.9% | 3.5% | Pharmaceuticals & Biotech | ||
COLB | US$19.21 | 9.8% | -3.8% | US$4.0b | US$21.42 | PB0.8x | E21.1% | 7.5% | Banks | ||
APLE | US$15.27 | 2.0% | 3.2% | US$3.7b | US$17.86 | PB1.1x | E8.2% | 6.6% | Real Estate | ||
CNXC | US$56.73 | 2.7% | -41.0% | US$3.7b | US$94.80 | PE13.8x | E29.2% | 2.1% | Commercial Services | ||
BHVN | US$38.72 | -12.1% | 194.9% | US$3.5b | US$57.89 | PB8x | E13.8% | n/a | Pharmaceuticals & Biotech | ||
AYX | US$48.26 | 0.06% | -14.5% | US$3.5b | US$49.81 | PS3.6x | E-2.9% | n/a | Software | ||
HI | US$48.95 | 4.7% | 11.6% | US$3.5b | US$63.00 | PE34.3x | E31.5% | 1.8% | Capital Goods |